Clinical Trials Directory

Trials / Unknown

UnknownNCT02644330

Minimally Invasive Transthoracic Device Closure in Perimembranous Ventricular Septal Defect

A Randomized Controlled Trial of Minimally Invasive Transthoracic Device Closure in the Treatment of Patients With Perimembranous Ventricular Septal Defect

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital · Academic / Other
Sex
All
Age
3 Months
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of minimally invasive transthoracic device closure of ventricular septal defect. This is a multi-center randomized controlled trial. Because of the characteristics of this surgical clinical trials, surgeons, ultrasonic department doctors, anesthesiologists, operating room nurses and intensive care unit nurses are all need to be informed. Therefore the results of this trial need to be system evaluated through objective methods to reduce bias.

Detailed description

Several examinations need to be done in all the patients, including X-ray, electrocardiogram, echocardiogram, blood routine examination, liver and kidney function, electrolytes, coagulation function and infectious index checks. And they will be divided into two groups after they have obtained informed consent: surgical group (50 cases); closure group (50 cases). If the closure failed, the patients in closure group will be converted to surgical repair with cardiopulmonary bypass . Recheck X-ray, electrocardiogram, echocardiogram, blood routine examination, liver and kidney function and electrolytes need to be done in all the patients two days after operation. The patients were followed up by X-ray, electrocardiogram, echocardiogram at the first month, third month, sixth month and the first year.

Conditions

Interventions

TypeNameDescription
PROCEDUREtransthoracic device closureminimally invasive transthoracic device closure
PROCEDUREsurgical repairsurgical repair with cardiopulmonary bypass

Timeline

Start date
2015-10-01
Primary completion
2016-10-01
Completion
2017-10-01
First posted
2015-12-31
Last updated
2015-12-31

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02644330. Inclusion in this directory is not an endorsement.